Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > ULURU Inc. Presents Nanoparticle Wound Care Technology at the Society for Biomaterials 2007 Annual Meeting and Exposition

Abstract:
- Data Indicate Potential to Significantly Accelerate Wound Healing -
- Technology for Controlled Release of Actives into Wounds -

ULURU Inc. Presents Nanoparticle Wound Care Technology at the Society for Biomaterials 2007 Annual Meeting and Exposition

ADDISON, TX | Posted on April 23rd, 2007

ULURU Inc. (OTC
Bulletin Board: ULUR) announced that its nanoparticle aggregate technology
was presented today at the Society for Biomaterials 2007 Annual Meeting and
Exposition. This presentation was given by Dr. John St. John, Vice
President of Material Science, a co-inventor of the technology, during the
Regenerative Medicine and Clinical Translation II (wound healing) session
of the meeting.

The presentation titled "Immediate Shape-Retentive Wound Dressings
Formed In Situ Using Hydrogel Nanoparticle Powders" is the first scientific
presentation of this exciting new technology. The presentation initially
focused on the methods for the synthesis, purification and the physical
properties of the material. Wound healing data, in porcine full-thickness
wounds and skin graft donor site models, also presented demonstrating the
superiority of the nanoparticle aggregate dressing, compared with a leading
commercial product, to accelerate wound healing.

Results presented by Dr. St. John demonstrated the ability to control
the release of drugs and proteins from the nanoparticle dressing for a
period of time in excess of 30 days. This unique property of the
nanoparticle aggregate wound dressing offers the exciting opportunity of
controlling the release of growth factors and other actives to accelerate
wound healing.

A summary of the attributes of the nanoparticle aggregate technology
included:

* Forms a film in situ sealing the wound and allowing conformation to
irregular wound surfaces
* Adheres to the wound but does not harm the healing tissue
* The dressing is moisture vapor and oxygen permeable
* Substantially decreases the need for multiple dressing changes
* Active healing agents can be trapped between the nanoparticles to
control the release of these actives to promote wound healing

Commenting on this presentation Dr. Spencer A. Brown, Director of
Research, Plastic Surgery Department University of Texas Southwestern
Medical center of Dallas, a co-author of the paper, stated, "At the
University of Texas Southwestern Medical Center we have extensively
evaluated this material both as a non-medicated dressing and an advanced
wound dressing incorporating a variety of actives including numerous growth
factors. The results achieved to date are very impressive in all the model
systems we have evaluated. We believe that this material offers great
promise to significantly advance the treatment of wounds and not only
accelerate the wound healing process but also reduce the nursing burden and
cost of patient care."

####

About ULURU Inc.
ULURU Inc. is an emerging specialty pharmaceutical company focused on
the development of a portfolio of wound management, plastic surgery and
oral care products to provide patients and consumers improved clinical
outcomes through controlled delivery utilizing its innovative transmucosal
delivery system and Hydrogel Nanoparticle Aggregate technology. For further
information about ULURU Inc., please visit our website at
http://www.uluruinc.com .

This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as
amended, including but not limited to statements made relating to the
projected benefits of the nanoparticle aggregate dressing and the promise
for improving wound healing. These statements are subject to numerous risks
and uncertainties, including but not limited to the risk factors detailed
in the Company's Annual Report on Form 10-KSB for the year ended December
31, 2006 and other reports filed by us with the Securities and Exchange
Commission.

For more information, please click here

Contacts:
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Exotic insulator may hold clue to key mystery of modern physics: Johns Hopkins-led research shows material living between classical and quantum worlds December 8th, 2016

Events/Classes

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project